Levetiracetam as a possible cause of fulminant liver failure.
Tan
T C H
TC
Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6008 Australia. perthfracp@gmail.com
de Boer
B W
BW
Mitchell
A
A
Delriviere
L
L
Adams
L A
LA
Jeffrey
G P
GP
Macquillan
G
G
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects / Q000469:parasitology / Q000503:physiopathology; D004827:Epilepsy / Q000188:drug therapy* / Q000469:parasitology; D006801:Humans; D000077287:Levetiracetam; D008099:Liver / Q000187:drug effects* / Q000503:physiopathology; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D020019:Neurocysticercosis / Q000150:complications; D010672:Phenytoin / Q000009:adverse effects; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000927:Anticonvulsants; D000077287:Levetiracetam; D010672:Phenytoin; D010889:Piracetam